Vivos Therapeutics (VVOS) Financial Statements

234 Followers

Vivos Therapeutics Financial Overview

Vivos Therapeutics's market cap is currently $9.73M. The company's EPS TTM is $-2.3; its P/E ratio is -0.41; Vivos Therapeutics is scheduled to report earnings on May 20, 2026, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	$ 17.44M	$ 15.03M	$ 13.80M	$ 16.02M	$ 16.89M
Gross Profit	$ 10.54M	$ 9.02M	$ 8.27M	$ 10.02M	$ 12.60M
Operating Income	$ -19.89M	$ -11.17M	$ -17.30M	$ -25.03M	$ -19.47M
EBITDA	$ -18.59M	$ -10.59M	$ -16.68M	$ -24.36M	$ -19.54M
Net Income	$ -21.23M	$ -11.14M	$ -13.58M	$ -23.84M	$ -20.29M
Balance Sheet
Cash & Short-Term Investments	$ 2.03M	$ 6.26M	$ 1.64M	$ 3.52M	$ 24.03M
Total Assets	$ 25.15M	$ 15.28M	$ 10.73M	$ 13.72M	$ 33.69M
Total Debt	$ 13.50M	$ 1.51M	$ 2.00M	$ 2.41M	$ 1.63M
Net Debt	$ 11.47M	$ -4.75M	$ 352.00K	$ -1.11M	$ -22.40M
Total Liabilities	$ 26.70M	$ 7.33M	$ 10.32M	$ 8.92M	$ 8.15M
Stockholders' Equity	$ -1.49M	$ 7.95M	$ 411.00K	$ 4.80M	$ 25.54M
Cash Flow
Free Cash Flow	$ -17.60M	$ -13.26M	$ -12.75M	$ -20.51M	$ -18.13M
Operating Cash Flow	$ -15.26M	$ -12.69M	$ -11.95M	$ -19.59M	$ -15.73M
Investing Cash Flow	$ -7.53M	$ -568.00K	$ -853.00K	$ -924.00K	$ -2.61M
Financing Cash Flow	$ 18.56M	$ 17.88M	$ 10.92M	$ 0.00	$ 24.17M

Currency in USD

Vivos Therapeutics Earnings and Revenue History

Income Statement >

Vivos Therapeutics Debt to Assets

Balance Sheet >

Vivos Therapeutics Cash Flow

Cash Flow >

Vivos Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >